The current status of histamine receptors in human skin: therapeutic implications

1981 ◽  
Vol 104 (5) ◽  
pp. 601-601 ◽  
Author(s):  
M.G. D avies ◽  
M.W. G reaves
1998 ◽  
Vol 110 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Bruch-Gerharz Daniela ◽  
Ruzicka Thomas ◽  
Victoria Kolb-Bachofen

2017 ◽  
Vol 148 (5) ◽  
pp. 218-224 ◽  
Author(s):  
Susana Conde Diez ◽  
Ricardo de las Cuevas Allende ◽  
Eulogio Conde García

2013 ◽  
Vol 2013 ◽  
pp. 1-18 ◽  
Author(s):  
Djamila Bennabi ◽  
Pierre Vandel ◽  
Charalambos Papaxanthis ◽  
Thierry Pozzo ◽  
Emmanuel Haffen

Psychomotor retardation is a central feature of depression which includes motor and cognitive impairments. Effective management may be useful to improve the classification of depressive subtypes and treatment selection, as well as prediction of outcome in patients with depression. The aim of this paper was to review the current status of knowledge regarding psychomotor retardation in depression, in order to clarify its role in the diagnostic management of mood disorders. Retardation modifies all the actions of the individual, including motility, mental activity, and speech. Objective assessments can highlight the diagnostic importance of psychomotor retardation, especially in melancholic and bipolar depression. Psychomotor retardation is also related to depression severity and therapeutic change and could be considered a good criterion for the prediction of therapeutic effect. The neurobiological process underlying the inhibition of activity includes functional deficits in the prefrontal cortex and abnormalities in dopamine neurotransmission. Future investigations of psychomotor retardation should help improve the understanding of the pathophysiological mechanisms underlying mood disorders and contribute to improving their therapeutic management.


1998 ◽  
Vol 26 (2) ◽  
pp. 195-211 ◽  
Author(s):  
Philip A. Botham ◽  
Lesley K. Earl ◽  
Julia H. Fentem ◽  
Roland Roguet ◽  
Johannes J.M. van de Sandt

The ECVAM Skin Irritation Task Force was established in November 1996, primarily to prepare a report on the current status of the development and validation of alternative tests for skin irritation and corrosion and, in particular, to identify any appropriate non-animal tests for predicting human skin irritation which were sufficiently well-developed to warrant ECVAM supporting their prevalidation/validation. The task force based its discussions around the proposed testing strategy for skin irritation/corrosion emanating from an OECD workshop held in January 1996. The following have been reviewed: a) structure-activity and structure-property relationships for skin corrosion and irritation; b) the use of pH and acid/alkaline reserve measurements in predicting skin corrosivity; c) in vitro tests for skin corrosion; d) in vitro tests for skin irritation (keratinocyte cultures, organ cultures, and reconstituted human skin models); and e) human patch tests for skin irritation. It was apparent that, although several promising candidate in vitro tests for skin irritation (for example, reconstituted human skin methods, and human and animal skin organ culture methods) were under development and evaluation, a test protocol, a preliminary prediction model and supporting data on different types of chemicals were only available for a method employing EpiDerm™. Thus, it is proposed that this EpiDerm test undergoes prevalidation during 1998. In addition, since it was felt preferable to be able to include other in vitro tests in such a prevalidation study, it is recommended that a “challenge” be set to anyone interested in taking part. This involves submitting data on ten test chemicals selected by the task force, obtained according to a standard protocol with a preliminary prediction model, for review by the task force by 31 May 1998.


Genes ◽  
2020 ◽  
Vol 11 (11) ◽  
pp. 1372
Author(s):  
Kaladhar B. Reddy

Cancer stem cells (CSCs) are a class of pluripotent cells that have been observed in most types of cancers. Evolving evidence suggests that CSCs, has the ability to self-renew and initiate tumors, may be responsible for promoting therapeutic resistance, tumor recurrence and metastasis. Tumor heterogeneity is originating from CSCs and its progenitors are recognized as major difficulty in efficaciously treating cancer patients. Therefore, understanding the biological mechanisms by which CSCs survive chemo- and-radiation therapy has the potential to identify new therapeutic strategies in the future. In this review, we summarized recent advances in CSC biology and their environment, and discuss about the potential therapies to prevent therapeutic resistance.


2018 ◽  
Vol 12 (1) ◽  
pp. 37-49 ◽  
Author(s):  
Antonio Miranda-Duarte

Background: Primary Osteoarthritis (OA) is a multifactorial disease in which genetic factors are strongly associated with its development; however, recently it has been observed that epigenetic modifications are also involved in the pathogenesis of OA. DNA methylation is related to gene silencing, and several studies have investigated its role in the loci of different pathways or molecules associated to OA. Objective: This review is focused on the current status of DNA methylation studies related to OA pathogenesis. Method: A review of the literature was conducted on searching in PUBMED for original papers on DNA methylation in OA. Conclusion: The DNA methylation research of loci related to OA pathogenesis has shown a correlation between methylation and gene repression; however, there are some exceptions to this rule. Recently, the development of genome-wide methylation and genome-wide hydroxymethylation profiles has demonstrated that several genes previously associated with OA can have changes in their methylation status, favoring the development of the disease, and these have even shown the role of other epigenetic markers.


2020 ◽  
Vol 41 (1) ◽  
pp. 275-313 ◽  
Author(s):  
Antonis S. Manolis ◽  
Antonis A. Manolis ◽  
Theodora A. Manolis ◽  
Naomi E. Apostolaki ◽  
Evdoxia J. Apostolopoulos ◽  
...  

2013 ◽  
Vol 52 (2) ◽  
pp. 262-267 ◽  
Author(s):  
Michał Pikuła ◽  
Maria E. Żebrowska ◽  
Loretta Pobłocka-Olech ◽  
Mirosława Krauze-Baranowska ◽  
Małgorzata Sznitowska ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document